Vasodilators in pulmonary hypertension.
作者信息
Peacock A
出版信息
Thorax. 1993 Dec;48(12):1196-9. doi: 10.1136/thx.48.12.1196.
Abstract
摘要
相似文献
1
Vasodilators in pulmonary hypertension.肺动脉高压中的血管扩张剂
Thorax. 1993 Dec;48(12):1196-9. doi: 10.1136/thx.48.12.1196.
2
Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators?患有肺动脉高压和肺阻力增加的患者应该用血管扩张剂治疗吗？
Cardiovasc Clin. 1990;21(1):265-74; discussion 275-6.
3
Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways.慢性肺部疾病中的低氧性肺动脉高压：新的血管收缩途径。
Lancet Respir Med. 2016 Mar;4(3):225-36. doi: 10.1016/S2213-2600(15)00517-2. Epub 2016 Feb 16.
4
The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular?血管扩张剂在肺动脉高压中的作用：肺血管还是外周血管？
Circ Heart Fail. 2009 Mar;2(2):145-50. doi: 10.1161/CIRCHEARTFAILURE.108.805374.
5
Calcium blockage in pulmonary hypertension and hypoxic vasoconstriction.肺动脉高压和低氧性血管收缩中的钙阻滞
New Horiz. 1996 Feb;4(1):99-106.
6
The treatment of primary pulmonary hypertension.原发性肺动脉高压的治疗
Br Heart J. 1991 Aug;66(2):119-21. doi: 10.1136/hrt.66.2.119.
7
Vasodilators ineffective in secondary pulmonary hypertension.
N Engl J Med. 1980 Oct 30;303(18):1062-3. doi: 10.1056/NEJM198010303031814.
8
[Vasodilators in "primary" pulmonary hypertension?].["原发性"肺动脉高压中的血管扩张剂？]
G Ital Cardiol. 1990 Feb;20(2):123-25.
9
[Effects of vasodilators on pulmonary hypertension].[血管扩张剂对肺动脉高压的影响]
Kokyu To Junkan. 1986 Sep;34(9):977-83.
引用本文的文献
1
Genetic Delivery and Gene Therapy in Pulmonary Hypertension.遗传性肺动脉高压的基因传递和基因治疗。
Int J Mol Sci. 2021 Jan 25;22(3):1179. doi: 10.3390/ijms22031179.
2
Primary pulmonary hypertension.原发性肺动脉高压
Thorax. 1999 Dec;54(12):1107-18. doi: 10.1136/thx.54.12.1107.
本文引用的文献
1
The role of endothelium in hypoxic constriction of human pulmonary artery rings.
Am Rev Respir Dis. 1993 Feb;147(2):283-90. doi: 10.1164/ajrccm/147.2.283.
2
Inhibition of hypoxic pulmonary vasoconstriction by nifedipine.硝苯地平对缺氧性肺血管收缩的抑制作用。
N Engl J Med. 1981 Jun 25;304(26):1582-5. doi: 10.1056/NEJM198106253042606.
3
Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.原发性肺动脉高压中血管扩张剂药物作用的重新评估：确定肺血管扩张剂反应的指南
Am Heart J. 1983 Jan;105(1):119-27. doi: 10.1016/0002-8703(83)90288-0.
4
Partial reversibility of chronic pulmonary hypertension caused by pulmonary thromboembolic disease.
Am Rev Respir Dis. 1981 Aug;124(2):129-31. doi: 10.1164/arrd.1981.124.2.129.
5
Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short- and long-term oxygen.慢性阻塞性肺疾病患者睡眠期间的心肺血流动力学。短期和长期吸氧的影响。
Chest. 1984 Jan;85(1):6-14. doi: 10.1378/chest.85.1.6.
6
Effects of verapamil on pulmonary haemodynamics during hypoxaemia, at rest, and during exercise in patients with chronic obstructive pulmonary disease.维拉帕米对慢性阻塞性肺疾病患者低氧血症时、静息时及运动时肺血流动力学的影响。
Thorax. 1983 Nov;38(11):840-4. doi: 10.1136/thx.38.11.840.
7
Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension.肼屈嗪对慢性阻塞性肺疾病合并肺动脉高压患者血流动力学、通气及气体交换的影响。
Am Rev Respir Dis. 1984 Oct;130(4):606-11. doi: 10.1164/arrd.1984.130.4.606.
8
Hemodynamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise.
Am Rev Respir Dis. 1984 Sep;130(3):391-5. doi: 10.1164/arrd.1984.130.3.391.
9
Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin).持续静脉输注依前列醇（前列环素）对原发性肺动脉高压的长期治疗
Lancet. 1984 May 12;1(8385):1046-7. doi: 10.1016/s0140-6736(84)91452-1.
10
Effects of oral and inhaled salbutamol and oral pirbuterol on right and left ventricular function in chronic bronchitis.口服和吸入沙丁胺醇及口服吡布特罗对慢性支气管炎患者左右心室功能的影响
Br Med J (Clin Res Ed). 1984 Mar 17;288(6420):824-5. doi: 10.1136/bmj.288.6420.824.
Zotero 插件